Wilmer Cutler Pickering Hale and Dorr represented Telix Pharmaceuticals Limited in the transaction. Telix Pharmaceuticals Limited (ASX: TLX) (Telix), a biopharmaceutical company, announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised MKS Instruments, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. MKS...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr is representing WEX in the transaction. WEX (NYSE: WEX) announced the signing of a definitive agreement to acquire Payzer. Pursuant to...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented MKS Instruments, Inc. in the deal. MKS Instruments, Inc. (NASDAQ:MKSI) announced the repricing of its existing $3.6 billion secured tranche...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Akamai Technologies, Inc., and Davis Polk & Wardwell advised the representatives of the initial purchasers in the offering. Akamai...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr LLP advised WEX, Inc. on the deal. WEX, Inc., a leading financial technology service provider, announced the refinancing of its...
You must be a Standard 1 Year member to access this content.
